Imbrium Therapeutics Announces U.S. FDA Orphan Drug Designation for Etoposide Toniribate for the Treatment of Relapsed Refractory Biliary Tract Cancer

Imbrium Therapeutics L.P. a clinicalstage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P. in conjunction with Mundipharma EDO GmbH today announced that the U.S. Food and Drug Administration FDA has granted o...